Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents

Circulation: Cardiovascular Interventions

Volumn 8, Issue 1, 2015, Pages

  Kang, Soo Jin ^a,b   Mintz, Gary S ^a   Witzenbichler, Bernhard ^c   Metzger, D Christopher ^d   Rinaldi, Michael J ^e   Duffy, Peter L ^f   Weisz, Giora ^a,g   Stuckey, Thomas D ^h   Brodie, Bruce R ^h   Shimizu, Takehisa ^a   Xu, Ke ^a   Kirtane, Ajay J ^a   Stone, Gregg W ^a   Maehara, Akiko ^a  

^a Department of Medicine   (United States)

^b Asan Medical Center   (South Korea)

^c Helios Amper Klinikum   (Germany)

^d Wellmont CVA Heart Institute   (United States)

^e LEVINE CANCER INSTITUTE   (United States)

^f Reid Heart Center   (United States)

^g SHAARE ZEDEK MEDICAL CENTER   (Israel)

^h LeBauer Cardiovascular Research Foundation   (United States)

Author keywords

Atherosclerosis; Obesity

Indexed keywords

ANTITHROMBOCYTIC AGENT; PACLITAXEL;

ADULT; AGED; ARTERY RUPTURE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVASCULARIZATION; BLOOD VESSEL TRANSPLANTATION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY THROMBOSIS; INTERVENTIONAL ULTRASONOGRAPHY; MORTALITY; MULTICENTER STUDY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; SURGERY; SURVIVAL ANALYSIS; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; UNITED STATES; UTILIZATION;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; BODY MASS INDEX; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; OBESITY; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; UNITED STATES;

EID: 84927729324     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.114.001392     Document Type: Article

References (21)

1. Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, Fuster V, Gotto A, Grundy SM, Miller NH, Jacobs A, Jones D, Krauss RM, Mosca L, Ockene I, Pasternak RC, Pearson T, Pfeffer MA, Starke RD, Taubert KA. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001;38:1581-1583
2. Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002;10(suppl 2):97-104
3. Kaplan RC, Heckbert SR, Furberg CD, Psaty BM. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol. 2002;55:654-664
4. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men withcardiovascular disease. Am Heart J. 2005;149:54-60. doi: 10.1016/j. ahj.2004.07.009
5. Rana JS, Mukamal KJ, Morgan JP, Muller JE, Mittleman MA. Obesity and the risk of death after acute myocardial infarction. Am Heart J. 2004;147:841-846. doi: 10.1016/j.ahj.2003.12.015
6. Hoit BD, Gilpin EA, Maisel AA, Henning H, Carlisle J, Ross J Jr. Influence of obesity on morbidity and mortality after acute myocardial infarction. Am Heart J. 1987;114:1334-1341
7. Mehta L, Devlin W, McCullough PA, O'Neill WW, Skelding KA, Stone GW, Boura JA, Grines CL. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;99:906-910. doi: 10.1016/j. amjcard.2006.11.038
8. Park DW, Kim YH, Yun SC, Ahn JM, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ. Association of body mass index with major cardiovascular events and with mortality after percutaneous coronary intervention. Circ Cardiovasc Interv. 2013;6:146-153. doi: 10.1161/CIRCINTERVENTIONS.112.000062
9. Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, Gurbel PA, Xu K, Parise H, Kirtane AJ, Brodie BR, Mehran R, Stuckey TD; ADAPT-DES Investigators. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet. 2013;382:614-623. doi: 10.1016/S0140-6736(13)61170-8
10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351. doi: 10.1161/CIRCULATIONAHA.106.685313
11. Maehara A, Cristea E, Mintz GS, Lansky AJ, Dressler O, Biro S, Templin B, Virmani R, de Bruyne B, Serruys PW, Stone GW. Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. JACC Cardiovasc Imaging. 2012;5(suppl 3): S1-S9. doi: 10.1016/j.jcmg.2011.11.019
12. Rossi R, Iaccarino D, Nuzzo A, Chiurlia E, Bacco L, Venturelli A, Modena MG. Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease. Nutr Metab Cardiovasc Dis. 2011;21:86-93. doi: 10.1016/j. numecd.2009.09.001
13. Auer J, Weber T, Berent R, Lassnig E, Maurer E, Lamm G, Kvas E, Eber B. Obesity, body fat and coronary atherosclerosis. Int J Cardiol. 2005;98:227-235. doi: 10.1016/j.ijcard.2003.11.007
14. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ; SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004;43:1959-1963. doi: 10.1016/j.jacc.2004.01.044
15. Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, Kim YH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:1305-1310. doi: 10.1093/eurheartj/ehi882
16. Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv. 2009;2:1269-1275. doi: 10.1016/j.jcin.2009.10.005
17. Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2014;83:873-878. doi: 10.1002/ccd.24560
18. Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM, Nissen SE. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol. 2010;55:2399-2407. doi: 10.1016/j.jacc.2010.02.026
19. Kato M, Dote K, Naganuma T, Sasaki S, Ueda K, Okita M, Watanabe Y, Kajikawa M, Yokoyama H, Higashi A. Clinical predictors of culprit plaque rupture assessed on intravascular ultrasound in acute coronary syndrome. Circ J. 2010;74:1936-1942
20. Kato M, Dote K, Sasaki S, Kagawa E, Nakano Y, Watanabe Y, Higashi A, Itakura K, Ochiumi Y, Takiguchi Y. Presentations of acute coronary syndrome related to coronary lesion morphologies as assessed by intravascular ultrasound and optical coherence tomography. Int J Cardiol. 2013;165:506-511. doi: 10.1016/j.ijcard.2011.09.032
21. Sánchez-Elvira G, Coma-Canella I, Artaiz M, Páramo JA, Barba J, Calabuig J. Characterization of coronary plaques with combined use of intravascular ultrasound, virtual histology and optical coherence tomography. Heart Int. 2010;5:e12. doi: 10.4081/hi.2010.e12.